Skip to main content

Archived Comments for: Diagnostic utility of BINAX NOW RSV – an evaluation of the diagnostic performance of BINAX NOW RSV in comparison with cell culture and direct immunofluorescence

Back to article

  1. Correction to Table 3

    Nteimam Jonathan, Health Protection Agency, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham B9 5SS UK

    27 July 2006

    Table 3 NPA 5months - 5years (n = 27). Cell culture sensitivity 2/4(50), not 4/4(50).

    Competing interests

    None declared